To access this element change to forms mode OFF
Grant Award View - GA279535
Translating and field-validating an epigenetic blood test to predict TB...
GA ID:
GA279535
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
27-Oct-2022
Publish Date:
23-Jan-2023
Category:
Medical Research
Grant Term:
1-Jan-2023 to 31-Dec-2025
Value (AUD):
$878,634.41
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 21/22 1.1 Health and Medical Research
Grant Program:
Ideas Grants
Grant Activity:
Translating and field-validating an epigenetic blood test to predict TB infection and disease risk
Purpose:
We will deliver a validated DNA blood test which can be used to identify asymptomatic individuals in at-risk communities who are infected with the tuberculosis bacteria and at risk of developing symptomatic disease over 3 years. Community screening asymptomatic individuals with this test has the potential to have the greatest impact on reducing TB cases, by allowing us to better target preventative therapy to those most in need, before they develop disease and transmit the bacteria to others.
GO ID:
GO Title:
Ideas Grants 2022
Internal Reference ID:
2022/GNT2020750
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
The Walter and Eliza Hall Institute of Medical Research
Recipient ABN:
12 004 251 423
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT, VIC, Overseas
Postcode:
Multiple
Country:
AUSTRALIA, UNITED KINGDOM, UNITED STATES